ASTRO 2014 Mirada RTx Adaptive Radiotherapy

September 24, 2014 — Mirada Medical software applied to state-of-the-art adaptive radiotherapy (ART) was the subject of an oral presentation at the annual conference of the American Society for Radiation Oncology (ASTRO) earlier this month in San Francisco.

A critical yet hugely time-consuming step in ART is the monitoring of patients throughout the course of therapy to determine which need to be replanned. This need presents a significant barrier to adoption of ART methods in the clinic. The original research, presented by collaborators from the University Medical Center, Groningen, The Netherlands, examined the possibility of using advanced image registration methods to automate patient monitoring and to flag only those patients that might need further investigation. Such a method can create significant time-savings.

The study included 28 locally advanced head and neck cancer patients treated with intensity-modulated radiation therapy (IMRT). For each patient, the planning target volumes and organs at risk were contoured on the planning computed tomography (CT) scan and propagated to a rescan using deformable image registration (Mirada RTx). Dose distributions of the treatment plan were calculated on both images.

Replanning decisions are usually made by applying constraints to the recalculated dose on the rescan, using the warped structures. However, as a surrogate for recalculation, a dose projection method using a rigid translation applied to the original dose mapped onto the rescan was used. The same set of constraints was then applied to this resulting dose, in order to decide whether a replan was required. The results showed the automated dose projection method correctly removed 90 percent of cases from further evaluation while identifying 100 percent of those that required investigation. This indicates rigid dose projection onto rescan CTs is a fast and automated substitute for dose recalculation since full recalculation and replanning decisions need only be made on those patients flagged by the system.

The study forms part of Mirada’s Registration Assurance program, a comprehensive program for ensuring DIR quality and continuous improvement through rigorous scientific validation of technology, education, comprehensive QC tools and a commitment to ongoing development and support. The registration, contouring and adaptive replanning workflows used in the study are all available in the new releases of Mirada RTx and Mirada Workflow Box.

For more information: www.mirada-medical.com


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
News | Proton Therapy

July 5, 2023 — RaySearch Laboratories AB announced a strategic collaboration agreement with B dot Medical Inc. aimed at ...

Time July 05, 2023
arrow
News | Radiation Oncology

May 31, 2023 — Elekta announced the launch of the first phase of Elekta ONE*, its most comprehensive and advanced ...

Time May 31, 2023
arrow
News | Radiation Therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
News | Radiation Therapy

October 23, 2022 — Meeting with a medical physicist who can explain how radiation therapy is planned and delivered ...

Time October 23, 2022
arrow
News | Treatment Planning

September 12, 2022 — Sunnybrook Health Sciences Centre, one of Canada’s largest hospitals, offers a highly specialized ...

Time September 12, 2022
arrow
News | Radiation Therapy

July 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time July 14, 2022
arrow
Feature | Treatment Planning | Information provided by Grand View Research

The global treatment planning systems and advanced image processing market size was valued at USD 1.7 billion in 2021 ...

Time July 07, 2022
arrow
News | Radiation Therapy

June 17, 2022 — Accuray Incorporated and Limbus AI Inc. announced they are partnering to augment Accuray adaptive ...

Time June 17, 2022
arrow
Subscribe Now